What is the preferred antibiotic regimen for an adult post‑craniotomy patient with a tracheostomy and sepsis caused by multidrug‑resistant Acinetobacter baumannii with suspected meningitis?

Management of MDR Acinetobacter baumannii with Suspected Meningitis in Post-Craniotomy Patient

For this post-craniotomy patient with tracheostomy, sepsis, and suspected MDR Acinetobacter baumannii meningitis, initiate intravenous polymyxin (colistin) combined with intraventricular/intrathecal colistin (125,000 IU daily), plus high-dose intravenous ampicillin-sulbactam (9-12 g/day sulbactam component in 3 divided doses) if the isolate has MIC ≤4 mg/L for sulbactam. 1

Systemic Antibiotic Therapy

Primary Regimen for Suspected Meningitis

• Intravenous colistin is the cornerstone for carbapenem-resistant A. baumannii (CRAB) meningitis, as carbapenems should not be used in areas with high resistance rates 1
• However, IV colistin alone achieves poor cerebrospinal fluid penetration even with inflamed meninges, making combination therapy essential 1
• Add high-dose ampicillin-sulbactam (9-12 g/day of sulbactam component divided every 8 hours) if susceptibility testing shows MIC ≤4 mg/L 1
  • Ampicillin-sulbactam demonstrates superior safety profile compared to polymyxins, with lower nephrotoxicity rates (15.3% vs 33%) 1
  • CNS penetration of sulbactam ranges from 1-33% depending on meningeal inflammation 1
  • Recent evidence suggests ampicillin-sulbactam may be more effective than colistin for CRAB infections, with lower mortality rates 2, 3

Critical Caveat for Empirical Coverage

• This patient meets criteria for empirical A. baumannii coverage: post-neurosurgical setting with sepsis in a patient with invasive devices (tracheostomy) 1
• Do not use carbapenems, tigecycline, or sulbactam as monotherapy for empirical treatment of suspected CRAB 1

Intrathecal/Intraventricular Therapy - Essential for CNS Infection

The combination of parenteral plus intrathecal (IT) or intraventricular (IVT) colistin is necessary to achieve therapeutic CNS concentrations and eradicate A. baumannii. 1

Colistin IT/IVT Dosing Protocol

• Standard dose: 125,000 IU (10 mg) once daily via IT or IVT route 1, 4
• Consider loading dose of 500,000 IU for rapid CNS penetration 1
• Successful clinical and bacteriological outcomes achieved in 89% of 83 patients treated with IT/IVT colistin 1, 4
• Median time to CSF sterilization: 4 days 4, 5

Alternative IT/IVT Options

• Aminoglycosides (amikacin or tobramycin) if strain is susceptible 1, 6
  • Amikacin: 10-50 mg daily IT/IVT
  • Tobramycin: 5-20 mg daily IT/IVT
• Tigecycline IT/IVT has been used successfully in case reports for XDR strains, though evidence is limited 7, 8

Duration and Monitoring

• Continue antimicrobial therapy for 21 days (3 weeks) 1
• Monitor CSF sterilization to guide duration of therapy 1
• Require three negative CSF cultures on separate days before discontinuing IT/IVT treatment 1

Management of Tracheostomy-Related Respiratory Colonization/Infection

Nebulized Antibiotic Adjunct

• Add nebulized colistin (2 million IU every 8-12 hours) if concurrent ventilator-associated pneumonia or tracheobronchitis is present 1
• Use ultrasonic or vibrating plate nebulizers for optimal drug delivery 1
• Nebulized antibiotics must be combined with IV therapy for pneumonia, never used as monotherapy 1
• Do not use nebulized antibiotics for simple colonization without active infection 1

Critical Pitfalls to Avoid

Monotherapy Failures

• Never use IV colistin alone for meningitis - CSF penetration is inadequate without IT/IVT administration 1, 9
• Tigecycline IV alone is not recommended for meningitis due to poor pharmacodynamics 9
• Sulbactam or tigecycline monotherapy should be avoided for severe infections 1

Toxicity Monitoring

• Monitor renal function closely - colistin nephrotoxicity occurs in approximately 33% of patients 1
• Chemical ventriculitis/meningitis from IT/IVT colistin occurs in ~11% of cases but is typically reversible 4
• Ampicillin-sulbactam demonstrates better safety profile with lower nephrotoxicity compared to polymyxins 2, 6

Hardware Management

• Consider removal or externalization of infected neurosurgical hardware (ventricular drains, shunts) for optimal outcomes 9, 3
• Continuous lumbar external drainage may be necessary adjunct 6

Susceptibility-Guided Adjustments

Once susceptibility results are available:

• If sulbactam MIC ≤4 mg/L: Prefer ampicillin-sulbactam over polymyxins due to better safety profile and potentially superior efficacy 1, 2
• If aminoglycoside-susceptible: Consider adding IT/IVT aminoglycoside as alternative to colistin 1, 6
• If only colistin-susceptible: Continue polymyxin-based regimen with mandatory IT/IVT administration 1, 4